Xilio Therapeutics (XLO) announced the appointment of Caroline Hensley as chief legal officer. Hensley most recently served as senior vice president, assistant general counsel and chief compliance officer at Seres Therapeutics (MCRB).
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XLO:
- Xilio Therapeutics Reports Q3 2024 Progress and Financials
- Xilio Therapeutics Advances Cancer Drug and Financial Outlook
- Xilio Therapeutics announces initial data from Phase 1C trial for XTX101
- Xilio Therapeutics expects cash to fund operations into Q2 of 2025
- Xilio Therapeutics reports Q3 EPS (22c), consensus (25c)